Home > Category > Signaling Pathways > Angiogenesis > VEGFR > Axitinib (AG-013736)

Axitinib (AG-013736)

ChemLeader 98+%

Catalog No：CL1637 CAS No.：319460-85-0 MDLNo： Formula：C22H18N4OS MW：386.47

Collect Share

Size	Availability	Price(USD)	VIP Price (USD)	Quantity
100 mg	In-stock	$148.00	Visible after login	- +
200 mg	In-stock	$238.00	Visible after login	- +
500 mg	In-stock	$398.00	Visible after login	- +

Chemical safety data sheet(MSDS)

Download MSDS

Certificate Of Authenticity(CPA)

Download COA

Inquiry Add To Cart

Product Overview
Related documents
Product details
Related literature

Product Overview

Product Name	Axitinib (AG-013736)
CAS	319460-85-0
Formula	C22H18N4OS
MW	386.47
Appearance	White to light yellow powder
Storage condition	Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years).

Product details

Axitinib (formerly AG013736; brand name Inlyta), is a potent, orally bioavailable, small molecule that inhibits multiple kinases and has the potential to treat cancer. In porcine aorta endothelial cells, it inhibits several kinases, including PDGFRβ, VEGFR1, VEGFR2, VEGFR3, and c-Kit, with IC50 values of 0.1 nM, 0.2 nM, 0.1-0.3 nM, 1.6 nM, and 1.7 nM, respectively. Axitinib has an anti-angiogenic effect by inhibiting the proangiogenic cytokines PDGF and VEGF.

Related literature

Sorry, there is no relevant literature

Sorry, no related items

History

CL1637

Axitinib (AG-013736)

319460-85-0 98+%